Sen. Rand Paul’s sudden release of a multi-year qualitative data set—previously known as Dr. Anthony Fauci’s private diary—has drawn sharp methodological criticism from the broader scientific community. Experts stress that the retrospective cohort is strictly limited to a sample size of one and relies entirely on unchecked subjective journaling.
The raw data, distributed by the Kentucky senator ahead of Wednesday’s Senate committee hearing on the origins of the coronavirus, spans hundreds of daily entries detailing the former NIH director’s mood fluctuations and breakfast choices. However, public health officials at the CDC immediately cautioned that these findings cannot be generalized to the broader population without a significantly larger cohort of octogenarian immunologists.
While the data regarding Dr. Fauci’s mild annoyance with Senate subcommittees is compelling, we must remember this is an unblinded narrative with no placebo diary for comparison.
A recent JAMA paper suggested that publicly releasing a rival's private notes is strongly associated with elevated political fundraising, though researchers were quick to emphasize the difference between association and causation. Furthermore, the diary entries did not undergo double-blind peer review before Paul published them, raising severe concerns about confirmation bias and the lack of a standardized diagnostic protocol.
At press time, medical professionals advised the public to treat the senator's findings as purely anecdotal, noting that significantly more research is needed to determine what, exactly, Paul thinks this proves.